NASDAQ:SABS | Key Financial Ratios | SAB Biotherapeutics, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-309.22-5.36%-5.95%
2026-03-3111.45-0.16%-0.18%
2025-12-319.467.68%8.76%
2025-09-3010.510.22%11.35%
2025-06-300.87-122.99%-308.38%
2025-03-311.69-89.92%-160.11%
2024-12-312.98-77.17%-131.33%
2024-09-303.69-84.70%-123.48%
2024-06-305.24-65.15%-87.43%
2024-03-315.65-55.86%-75.47%
2023-12-315.45-50.27%-73.64%
2023-09-300.34-96.03%-178.37%
2023-06-300.82-82.35%-148.03%
2023-03-311.1-63.46%-110.97%
2022-12-311.47-36.82%-60.34%
2022-09-301.3-42.69%-73.20%
2022-06-301.71-32.66%-52.27%
2022-03-311.93-25.65%-42.58%
2021-12-311.9-21.13%-44.47%
2021-09-302.39
2021-06-306.13
2021-03-3114.01
2020-12-313.11

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-319.467.68%8.76%
2024-12-312.98-77.17%-131.33%
2023-12-315.45-50.27%-73.64%
2022-12-311.47-36.82%-60.34%
2022-06-301.71
2022-03-311.93
2021-12-311.9-21.13%-44.47%
2020-12-313.1135.58%51.57%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.